As a result of these combined effects, most patients with T2D using GLP-1RAs experience an improvement in fasting serum insulin and insulin sensitivity (homeostasis model assessment for insulin resistance), a lowering of hemoglobin A1c levels, and a decreased reliance on supplemental insulin (12, 31)
Phase 3 TRIUMPH trials are ongoing, with early TRIUMPH-4 data showing 28.7% weight loss at 68 weeks
Avoid heavy, fatty, or highly processed foods, as they can slow your progress and may increase side effects
Approval doesn't mean immediate access coverage, supply, and titration capacity all gate the real availability ramp
Thats why this class of medications has made a significant difference for so many peoplebut the decision to use them is highly individual. For people whose bodies strongly resist weight loss, or who struggle with persistent food noise, GLP-1 medications can be a powerful support , especially when lifestyle changes alone havent been enough
This work is also supported by the Foundation for Polish Science (FNP)